Skip to main contentSkip to footer content

Latest News

TTUHSC Research Receives Prestigious Status as Carnegie Classification® for Special Focus Four-Year Research Institution

The Carnegie Classification® of Institutions of Higher Education has designated Texas Tech University Health Sciences Center (TTUHSC) as a Special Focus Four-Year Research Institution.

TTUHSC’s Reynolds Receives CPRIT Research Grant to Study Childhood Cancers

CPRIT awarded a four-year, $1.34 million grant to C. Patrick Reynolds, M.D., Ph.D., director for the School of Medicine Cancer Center at the Texas Tech University Health Sciences Center.

Bridging Academia and Industry to Advance Drone Technologies

Alongside Texas Tech University and 2THEDGE, a leading technology consulting and investing firm, TTUHSC unveiled the groundwork of a future public-private collaboration supporting the advancement of Unmanned Aerial Systems (UAS) research at a summit event on the TTUHSC campus Wednesday, April 6.

Pharmacy Researchers Receive Patent for Chemical Probe

Nadia German, Ph.D., and collaborator Constantinos Mikelis, Ph.D., have received a U.S. patent for a chemical that targets the brain’s dopamine transporter.

TTUHSC Researcher Receives NIH Grant to Study Vulnerabilities in Specific Cancer Types

The National Cancer Institute awarded a five-year, $1.9 million grant to C. Patrick Reynolds, M.D., Ph.D., director for the School of Medicine Cancer Center at TTUHSC.

TTUHSC Receives NIH Grant to Examine Impact of Vitamin A Depletion on Alzheimer’s Disease

To gain insight into the potential relationship between ROS accumulation in the dentate gyrus and the onset of Alzheimer’s disease, the National Institutes of Health recently awarded a five-year, $1.87 million grant to TTUHSC's J. Josh Lawrence, Ph.D.

Texas Tech University Health Sciences Center Researchers Achieve Global Recognition

The global preeminence of TTUHSC is highlighted by a widely publicized citation database created at Stanford University. The comprehensive database shows that TTUHSC is the academic home to several of the world’s top-ranked biomedical and pharmaceutical researchers.

TTUHSC’s Rahman Receives Grant Extension

In its most recent funding cycle, the Cancer Prevention & Research Institute of Texas (CPRIT) awarded a $2,499,999 grant extension to Rakhshanda Rahman, M.D., professor of breast surgical oncology at the Texas Tech University Health Sciences Center School of Medicine and the founding executive director of the school’s multi-campus Breast Center of Excellence (BCE).

TTUHSC’s Jansen Receives NIH Grant to Continue Study into Neurological Disorders

To continue her research, the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes for Health (NIH) recently awarded Michaela Jansen, Pharm.D., Ph.D., a four-year, $1.53 million grant.

NIH Awards Grant to TTUHSC Researcher

To better understand the role of extracellular vesicles in the spread and progression of LAM, the NIH recently awarded a four-year, $2.8 million grant to Magdalena Karbowniczek, M.D., Ph.D., a professor of immunotherapeutics and biotechnology at the TTUHSC Jerry H. Hodge School of Pharmacy.

TTUHSC Researchers Receive New NIH Grant to Continue Studying Amygdala-Pain Link

The National Institutes of Health (NIH) recently awarded a five-year, $2.76 million grant to Volker E. Neugebauer, M.D., Ph.D. and Igor Ponomarev, Ph.D.

TTUHSC Scientist Seeking Solution to Antibiotic Resistance

A team of researchers led by Hongjun (Henry) Liang, Ph.D., from the Texas Tech University Health Sciences Center (TTUHSC) Department of Cell Physiology and Molecular Biophysics, recently investigated whether or not a series of novel nanoparticles can kill some of the pathogens that lead to human infection without affecting healthy cells.

TTUHSC Researchers Receive Patent for Identifying Viable Embryos

The Texas Tech Office of Research Commercialization (ORC) filed an initial U.S. patent application in 2016, and a patent was awarded to Prien and Penrose on Nov. 8, 2021.

TTUHSC Technology Leads Successful Clinical Trial to Treat Dry Eye Disease

Hironmoy Das, Ph.D., a professor of pharmaceutical sciences at the Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy, developed a technology derived from corneal epithelial stem cells to improve outcomes for DED patients.

Study of CVD Risk Factors on Cognitive Dysfunction in Elderly Rural West Texans Presented in Journal of Alzheimer’s Disease Reports

A team of researchers led by P. Hemachandra Reddy, Ph.D., professor of internal medicine, neurology and neuroscience at the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine and Hafiz Khan, Ph.D., professor for the Julia Jones Matthews Department of Public Health at the TTUHSC Graduate School of Biomedical Sciences, completed a study to better understand the risk factors for cardiovascular disease (CVD), dementia and Alzheimer’s disease in a rural population.

TTUHSC Study: Pandemic, Restrictions Have Increased Mental Health Risks for Nursing Home Caregivers

Ashish Sarangi, M.D., recently conducted research into the mental health consequences of COVID-19 geriatric care in a nursing home setting. His research, “A Descriptive Study Evaluating the Impact of COVID-19 on Delivery of Care and Mental Health of Geriatric Nursing Home Staff,” was published in the April issue of the American Journal of Geriatric Psychiatry.

Journal Publishes Research Review by TTUHSC Pharmacy Investigator

In a focused review to Physiological Reports, Vardan Karamyan, Ph.D., addresses three peptides that could be causing severe COVID-19 complications

Faculty Honored at State of the University & Faculty Award Convocation

During a virtual presentation of the 2021 TTUHSC State of the University & Faculty Award Convocation, faculty members and teams were recognized for excellence in teaching, research, teamwork and more.

TTUHSC’s Phy Seeks Answers for Women With Polycystic Ovary Syndrome

Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in reproductive- aged women. It affects at least 10% of women, increasing their risk of obesity, diabetes, heart disease, cancer and infertility. To help improve the health of these women, a research team led by Jennifer Phy, D.O., an associate professor at the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine, developed a new dietary approach to managing the syndrome.

Study Shows a Healthy Heart Can Reduce Ocular Disease

At the Texas Tech University Health Sciences Center (TTUHSC), a research team led by Duke Appiah, Ph.D., an assistant professor and director of the university’s master of public health program, recently completed a study to better understand how LS7 may influence ocular health.

Tags